Caricamento...

Dupilumab and COVID‐19: What should we expect?

Coronavirus disease 2019 (COVID‐19) is a pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with high morbidity and mortality. There are very limited data on the interference of immunomodulating drugs on the risk of infection and on the course of the disease. In...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Dermatol Ther
Autori principali: Patruno, Cataldo, Stingeni, Luca, Fabbrocini, Gabriella, Hansel, Katharina, Napolitano, Maddalena
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7267436/
https://ncbi.nlm.nih.gov/pubmed/32362061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13502
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !